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Ovarian steroid cell tumours (not otherwise speciﬁed) are rare neoplasms of the ovary and are classiﬁed under lipid cell
tumours. Their diagnosis can be considered as one of exclusion. Histopathologically, the tumour should carefully be evaluated
for microscopic features of malignancy, but it is essential for the clinician and the pathologist to remember that in these tumours,
pathologically benign histomorphology does not exclude the possibility of clinically malignant behaviour. Our case study focuses
on the comparative ﬁndings in a postmenopausal female diagnosed with an ovarian steroid tumour (not otherwise speciﬁed). A
careful correlation between clinical and surgical evaluation and microscopic analysis is necessary, as is a regular followup.
1.Introduction
The spectrum of ovarian neoplasms covers an extremely
wide range of tumours. The best recognized of these are the
surface epithelial cell tumours. Amongst the less common
variants, lipid or steroid cell tumourscomprise an important
category, although they account for only 0.1% of all ovarian
tumours [1].
The origin of steroid cell tumours has long been a matter
of controversy and debate. Their nomenclature as such arises
from their resemblance to steroid hormone secreting cells
(lutein/leydig/adrenal cortical rest cells) [2]a n dt h e yh a v e
been basically subclassiﬁed as stromal luteomas, leydig cell
tumours, and steroid cell tumours, not otherwise speciﬁed
[3]. The term steroid cell tumours (not otherwise speciﬁed)
was ﬁrst described by Scully [4, 5] and signiﬁes that the cell
lineage is not deﬁned, and they cannot be categorized as
either stromal luteomas or leydig cell tumours [3]. However,
the majority of cases fall under this category [3, 4].
The following report focuses on a case of a steroid cell
tumour (not otherwise speciﬁed) diagnosed in a 54-year-
old postmenopausal female. The case was signiﬁcant keeping
in mind the short duration of complaints, the age of the
patient, lack of any overt androgenic manifestations, and
discrepancies between clinicopathological ﬁndings and light
microscopic features.
2.Case Report
A 54-year-old multiparous postmenopausal female pre-
sented in the outpatient section of the department of
obstetrics and gynecology in our hospital, with a short
h i s t o r yo fp a i ni nt h ea b d o m e n( i nt h ee p i g a s t r i cr e g i o n )f o r
two months, associated with abdominal distention and loss
of appetite for ﬁfteen days. There were no other associated
complaints.
Perabdominal examination revealed distention of the
abdomen. Pervaginal examination did not yield deﬁnite
ﬁndings, with a vague fullness being detected in both
fornices. Uterine size could not be made out.
ACTscanwascarried outwhich showed a heterogenous,
solid-cystic, right adnexal mass (Figure 1), associated with
normal uterine size and a leiomyoma in the posterior wall
of the uterus. Free ﬂuid was present in the peritoneal cavity.2 Pathology Research International
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Figure 1: CT Scan—Heterogenous, solid-cystic, moderately enhancing right adnexal mass (↑).
The patient underwent an exploratory laparotomy, with
total abdominal hysterectomy, bilateral salpingo-oopherec-
tomy and sampling of pelvic and mesenteric lymph nodes
and omentum. Imprint/scrape smears were prepared per-
operatively from the tumour surface, hemidiaphragm, liver,
and peritoneum and from what appeared to be deposits on
the omental and colonic surface. Fluid samples were also
collected from the subdiaphragmatic spaces and para-colic
gutters and pouch of Douglas. We did not attempt to assess
the tumour intraoperatively with frozen sections.
The resected specimens were sent to the histopathology
section ofthedepartment ofpathology,while the smears and
ﬂuid samples were received in the cytopathology section and
were processed as per the protocol.
2.1. Gross Examination. A ﬁrm yellow-coloured tumour was
seen at one end of the right ovary, 6 × 5 × 4cms in size, with
a nodular/bosselated surface. The cut surface was solid with
occasional small cystic spaces, yellowish and with focal areas
of haemorrhage. There was capsular extension with presence
of satellite nodules. The gross appearance is demonstrated in
Figure 2.
The rest of the ovary was occupied by a smooth cystic
cavity,4 × 3cms, containingwatery ﬂuid.The right fallopian
tube was grossly normal, as were the left tube and ovary. An
intramural leiomyoma, 1.5cms in diameter, was detected in
the posterior and lower segment of the uterus. Lymphnode
and omental samples were also processed.
2.2. Light Microscopy. On evaluation of the light micro-
scopic features, the tumour areas showed a bimodal cell
population; there were large, round to polyhedral cells with
vacuolated cytoplasm as well as smaller cells which had
eosinophilic granular cytoplasm (Figure 3). Some degree of
overcrowding, overlapping and nuclear atypia was clearly
evident in these smaller cells (Figure 4(a)). The nuclei were
predominantly vesicular and nucleoli were present in the
small cells. Reinke’s crystals were not observed. Mitotic
activity or necrosis was not seen in the sections examined
from the tumour site. The stroma was loose with several
vascular channels randomly distributed between the tumour
cells. A reticulin stain was applied and the resultant slide
showed ﬁne reticulin-positive ﬁbres around small groups of
2-3 tumour cells throughout the tissue (Figure 4(b)). ThePathology Research International 3
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Figure 2: Gross Appearance. (a) Specimen of resected uterus, cervix and bilateral tubes and ovaries, with a large nodular solid tumour in
right ovary. (b) Cut surface of tumour showing a predominantly solid, yellowish appearance with occasionalsmall cystic spaces.
presenceofglycogenwas excludedwith the help ofa negative
Periodic acid-Schiﬀ reaction.
The tumour tissue was also sent for immunohistochemi-
cal analysis for calretinin but the result was negative.
The associated cystic area in rest of the ovary turned out
to be a simple serous cyst. Other histopathological ﬁndings
included chronic cervicitis, an atrophic endometrium with
endometritis, myometritis, and an intramural leiomyoma,
salpingitis, and a simple serous cyst in the left ovary.
Reactive changes were noted in the mesenteric lymph
node, while the sample of pelvic lymphnode yielded only
ﬁbrofatty tissue. No tumour cell deposits were detected
on light microscopy in the sections of lymphnode and
omentum.
The cytologicsamples (ﬂuidand imprint smears) did not
yield any signiﬁcant ﬁndings.
The histopathological features supported a diagnosis of a
Lipid (Steroid) cell tumour (not otherwise speciﬁed) of the
right ovary with serosal nodules.
The patient was treated postoperatively with chemother-
apy and is on regular followup.
3.Discussion
The most important factor to be determined in lipid/steroid
cell tumours of the ovary is whether the tumour has
malignant features or not. In one of the major studies done
on lipid cell tumours of the ovary [4], certain histopatho-
logical ﬁndings were found to correlate highly with clinically
malignant behaviour. These can be summarized as 2 or more
mitotic ﬁgures per 10 high power ﬁelds (92%), necrosis
(86%), a diameter ≥7cms (78%), haemorrhage (77%), and
grade 2-3 atypia (64%).
It is interesting to note that in the case under discussion,
the patient had ascites and on gross examination, there was
evidence of capsular extension and satellite nodules.
In contrast to the clinical ﬁndings, the microscopic
appearance did not reveal any prominent ﬁnding in favour
of malignancy. Mitosis was not noted, there was no haem-
orrhage or necrosis, tumour size was less than 7cms in all
dimensions, and only grade 1 atypia was observed. This
tumour thus had a benign microscopic appearance.
It is known that pathologically benign steroid cell
tumours can behave in a clinically malignant fashion [6].
Therefore, careful followup is essential in such cases which
do not have clinical or pathological evidence of malignancy.
As such, presence of metastasis may be the only deﬁnite
evidence of malignant behavior [1]. Our patient has also
beenplacedonregularfollowup,aftertreatmentwithsurgery
and chemotherapy.
Another unusual ﬁnding in this case is the apparent
absence of androgenic manifestations. However, it is possible
that the changes were very subtle and not clinically evident.
Some of the other pathological entities that have to be
excluded are leydig cell tumors, luteinized granulosa cell
tumours, clear cell carcinomas, and metastatic renal cell
carcinomas. Reinke’s crystals can usually be demonstrated
in leydig cell tumours. Granulosa cell tumours can have
prominent luteinized areas but typical foci of the tumour
can be identiﬁed. A Periodic acid-Schiﬀ stain can be used to
demonstratethepresenceofglycogeninclearcellcarcinomas
and metastatic renal cell carcinomas, which is absent in
steroid cell tumours.
A calretinin stain was performed in this case but was
found to be negative. These tumours are usually positive
for inhibin although it is not speciﬁc for this tumour.
A recent study analysed ovarian sex-cord stromal tumours
for calretinin positivity [7]. All the six steroid cell tumours
in this study were positive for the marker. Calretinin can be
considered a sensitive marker for ovarian sex-cord stromal
tumoursingeneral,butislessspeciﬁc[8].Asimilar studyhas
evaluated the applicability of CD56 as a marker in ovarian
sex-cord stromal tumours [9]. The authors concludedthat it
is a sensitive marker for these neoplasms, although it cannot
help to diﬀerentiate a sex-cord stromal tumour from a
neuroendocrineneoplasm.Anumberofimmunohistochem-
ical markers were reviewed for their utility in diﬀerential
diagnosis of sex-cord stromal tumours and inhibin and
calretinin were found to be most useful, among others, in
diﬀerentiating sex-cord stromal from nonsex-cord stromal4 Pathology Research International
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Figure 3: (a) and (b) Bimodal tumour cell population; large polyhedral cells with vacuolated cytoplasm and smaller cells with
eosinophilic/granularcytoplasm in a vascular stroma (H&E ×125 ).
(a) (b)
Figure 4: (a)Tumour cells showing vesicular nuclei with nucleoli and nuclear atypia; mitotic ﬁgures are not seen (H&E ×500). (b) Diﬀuse
presence of ﬁne reticulin ﬁbres around small cell groups (Reticulin stain ×125).
tumours, while MART-1 was diagnostically useful for steroid
cell tumours [10].
A careful correlation between clinical ﬁndings and
histopathology is always essential, as is amply demonstrated
by this particular case. Moreover, the necessity of a regular
followup must be stressed upon, with the aim of detecting a
possible recurrence or evidence of distant metastasis.
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